Horizon Therapeutics PLC (HZNP)
115.74
+0.08
(+0.07%)
USD |
NASDAQ |
Sep 26, 16:00
115.89
+0.15
(+0.13%)
Pre-Market: 08:18
Horizon Therapeutics Enterprise Value: 26.56B for Sept. 26, 2023
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 26, 2023 | 26.56B |
| September 25, 2023 | 26.55B |
| September 22, 2023 | 26.54B |
| September 21, 2023 | 26.51B |
| September 20, 2023 | 26.53B |
| September 19, 2023 | 26.51B |
| September 18, 2023 | 26.48B |
| September 15, 2023 | 26.47B |
| September 14, 2023 | 26.48B |
| September 13, 2023 | 26.46B |
| September 12, 2023 | 26.48B |
| September 11, 2023 | 26.34B |
| September 08, 2023 | 26.49B |
| September 07, 2023 | 26.49B |
| September 06, 2023 | 26.51B |
| September 05, 2023 | 26.51B |
| September 01, 2023 | 26.46B |
| August 31, 2023 | 25.88B |
| August 30, 2023 | 25.90B |
| August 29, 2023 | 25.85B |
| August 28, 2023 | 25.74B |
| August 25, 2023 | 24.49B |
| August 24, 2023 | 24.41B |
| August 23, 2023 | 24.36B |
| August 22, 2023 | 24.17B |
| Date | Value |
|---|---|
| August 21, 2023 | 24.10B |
| August 18, 2023 | 23.84B |
| August 17, 2023 | 23.82B |
| August 16, 2023 | 23.90B |
| August 15, 2023 | 23.90B |
| August 14, 2023 | 23.88B |
| August 11, 2023 | 23.94B |
| August 10, 2023 | 24.03B |
| August 09, 2023 | 24.03B |
| August 08, 2023 | 23.89B |
| August 07, 2023 | 23.22B |
| August 04, 2023 | 22.99B |
| August 03, 2023 | 22.73B |
| August 02, 2023 | 22.73B |
| August 01, 2023 | 22.88B |
| July 31, 2023 | 23.02B |
| July 28, 2023 | 22.94B |
| July 27, 2023 | 22.86B |
| July 26, 2023 | 22.94B |
| July 25, 2023 | 23.01B |
| July 24, 2023 | 23.05B |
| July 21, 2023 | 23.22B |
| July 20, 2023 | 23.41B |
| July 19, 2023 | 23.88B |
| July 18, 2023 | 23.87B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.916B
Minimum
Oct 25 2018
28.70B
Maximum
Oct 29 2021
15.95B
Average
16.88B
Median
Jan 19 2021
Enterprise Value Benchmarks
| Amgen Inc | 171.21B |
| Pfizer Inc | 203.76B |
| Jazz Pharmaceuticals PLC | 12.76B |
| Perrigo Co PLC | 7.800B |
| Iterum Therapeutics PLC | -3.947M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 127.07M |
| Revenue (Quarterly) | 944.96M |
| Total Expenses (Quarterly) | 804.12M |
| EPS Diluted (Quarterly) | 0.54 |
| Gross Profit Margin (Quarterly) | 76.72% |
| Profit Margin (Quarterly) | 13.45% |
| Earnings Yield | 1.62% |
| Operating Earnings Yield | 2.10% |
| Normalized Earnings Yield | 1.761 |